logo

Quick Facts

Share

Pharmaceutical companies Mylan N.V. (MYL) and Fujifilm Kyowa Kirin Biologics Co., Ltd. announced Thursday that the U.S. Food and Drug Administration (FDA) has approved Hulio (adalimumab-fkjp), a biosimilar to AbbVie's Humira (adalimumab). This will help bring another affordable treatment option to U.S....

AIDA Cruises, Germany's leading cruise line and a part of cruise company Carnival Corp. & plc (CCL, CUK, CCL.L), announced Thursday that it will resume sailing operations in August 2020. After pausing operations in mid-March, three of AIDA Cruises' ships will restart sailing next month. AIDAperla...

Siemens AG (SIEGY.PK, SMAWF) announced Thursday that Michael Peter will be Siemens Mobility's sole CEO, effective July 10. Sabrina Soussan, Co-CEO until now, will leave the company at her own request to take on a new challenge outside Siemens. Soussan will remain available to Siemens Mobility in an...

Siemens AG (SIEGY.PK, SMAWF) announced Thursday that its shareholders will vote on its proposal to spin off 55 percent of Siemens Energy to them. Siemens shareholders would automatically receive one share of Siemens Energy AG for every two shares of Siemens AG. The shareholders will vote on the spin-off...

AstraZeneca (AZN.L, AZN) announced Thursday the US Food and Drug Administration has accepted a supplemental New Drug Application or sNDA and granted Priority Review for Brilinta (ticagrelor) for stroke. The Priority Review is for the reduction of subsequent stroke in patients who had an acute ischemic...

National Grid plc (NG.L, NGG) said it is "extremely disappointed" with the Ofgem's Draft Determination for RIIO-T2, which risks undermining the process established by Ofgem. As part of the ongoing process towards agreeing a settlement for RIIO-T2, Ofgem has today published its draft determination,...

C&C Group Plc (CCR.L), a premium drinks company, announced Thursday the appointment of David Forde as Group Chief Executive Officer. Forde, who is currently with beer and cider brands producer Heineken, will join C&C at the latest in early 2021. Further, C&C announced the appointment of Patrick McMahon,...

Südzucker (SUEZF.PK) reported that its first quarter group EBITDA rose to 134 million euros from 117 million euros in the prior year. The consolidated group operating result climbed to 61 million euros from 47 million euros in the prior year. Quarterly revenues declined to 1.669 billion euros from...

Seabras Group said it has emerged from Chapter 11 bankruptcy. The total outstanding debt of the company has been reduced, the debt maturity has been extended by about six years to September 2028, the debt amortization has been re-shaped. Coincident with the consolidation and Chapter 11 emergence,...

Acer Inc. reported preliminary second quarter consolidated revenues of NT$65.60 billion, up 34.3% quarter over quarter and by 19.0% year-on-year. Second quarter revenues grew quarter over quarter for notebook PCs by 48.4%, monitors by 28.9%, gaming line by 70.9%, and Chromebooks with 74.8%. For the...

Merck & Co, Inc. (MRK) and Eisai Co. Ltd. announced Wednesday that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding their applications seeking accelerated approval of Merck's Keytruda, plus Eisai's Lenvima, for the first-line treatment of patients with...

CVS Pharmacy (CVS) said the company has developed Spoken Rx, a new feature of the CVS Pharmacy app that can read a specific type of label for patients with visual impairments. The in-app prescription reader application will read prescription label information aloud in either English or Spanish. Spoken...

International Business Machines Corp. (IBM) said Wednesday that it has agreed to acquire WDG Soluções Em Sistemas E Automação De Processos LTDA or WDG Automation, a Brazilian software provider of robotic process automation or RPA. Financial terms of the deal were not disclosed. The transaction is...

Alcoa Corp. (AA) expects a net loss attributable to the company for the second-quarter to be between $205 million and $190 million, compared to net income attributable to the company of $80 million in the first quarter 2020. The expected sequential decrease was driven primarily by the non-recurrence...

Foghorn Therapeutics Inc. has entered into a strategic collaboration with Merck which will apply Foghorn's Gene Traffic Control product platform to discover and develop novel therapeutics against a transcription factor target believed to be relevant to a broad range of cancer patients. Foghorn will grant...

Follow RTT